Request Information
Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (Second Edition): 2024 Drug Supplement
- Publication Year:
- 2025
- Edition:
- 2024
- Author:
- Mikaela Olsen; Kristine B. Lefebvre; Suzanne L. Walker, et al.
- Publisher:
- The Oncology Nursing Society
- ISBN:
- 978-1-63-593070-2
-
Description
-
Details
-
Collections
Description
Significant advancements in cancer care have made this an exciting time to work in the oncology specialty, and it is critical that healthcare professionals have access to the most current information on cancer research.
The Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition): 2024 Drug Supplement is an up-to-date resource on the latest U.S. Food and Drug Administration (FDA)-approved antineoplastic agents from September 2021 through May 2024.
The 2024 Drug Supplement includes more than 30 new antineoplastic agents approved by FDA and their indications, mechanism of action, side effects, and nursing considerations. The information is organized in a user-friendly format for quick reference and is available in a digital format for easy access.
Details
- Platform:
- OvidSP
- Publisher:
- The Oncology Nursing Society
- Product Type:
- Book
- Author:
- Mikaela Olsen; Kristine B. Lefebvre; Suzanne L. Walker, et al.
- ISBN:
- 978-1-63-593070-2
- Specialty:
-
- Internal Medicine
- Oncology
- Pharmacology
- Language:
- English
- Edition:
- 2024
- Pages:
- 43
- Publication Year:
- 2025